[1]
Ebert, K.M. , Posid, T., Dall, C.P. , Shah, K.K. , Broutian, T. , Harbrecht, M.T. , Hudson, C. , Hundley, A. , Scimeca, A. and Bellows, F.F. 2021. Promoting patient followup treatment with intra-detrusor onabotulinumtoxinA for overactive bladder. Canadian Urological Association Journal. 15, 8 (Jan. 2021), E405–11. DOI:https://doi.org/10.5489/cuaj.6983.